Open AccessA Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients
Author(s) -
Hyung Joon Kim,
Ju Hyun Kim,
Jong Eun Yeon,
Yeon Seok Seo,
Jeong Won Jang,
Yong Kyun Cho,
Byoung Kuk Jang,
Byung Hoon Han,
Changhyeong Lee,
Joon Hyeok Lee,
Jung Hwan Yoon,
Kang Mo Kim,
Moon Young Kim,
Do Young Kim,
Neung Hwa Park,
Eun Young Cho,
June Sung Lee,
Jin-Woo Lee,
In Hee Kim,
ByungCheol Song,
Byungseok Lee,
Oh Sang Kwon
Publication year - 2022
Publication title -
journal of korean medical science/journal of korean medical science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.743
H-Index - 66
eISSN - 1598-6357
pISSN - 1011-8934
DOI - 10.3346/jkms.2022.37.e92
Subject(s) - medicine , hbeag , clinical endpoint , hbsag , adverse effect , hepatitis b virus , hepatitis b , gastroenterology , randomized controlled trial , dosing , virology , virus